We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.3B
AUM Growth
+$783M
(+4.2%)
Cap. Flow
-$455M
Cap. Flow
% of AUM
-2.35%
Top 10 Holdings %
Top 10 Hldgs %
20.28%
Holding
1,342
New
146
Increased
332
Reduced
638
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$37.2M |
| 2 |
Progressive
PGR
|
+$34.8M |
| 3 |
Northrop Grumman
NOC
|
+$24.6M |
| 4 |
Revvity
RVTY
|
+$24.1M |
| 5 |
Carrier Global
CARR
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.9M |
| 2 |
Fortinet
FTNT
|
+$36.2M |
| 3 |
Ameriprise Financial
AMP
|
+$35.9M |
| 4 |
Cadence Design Systems
CDNS
|
+$31M |
| 5 |
Broadstone Net Lease
BNL
|
+$30.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Healthcare | 12.4% |
| 3 | Financials | 11.64% |
| 4 | Consumer Discretionary | 9.19% |
| 5 | Industrials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Royalty Pharma
RPRX
$26B
| $916K | ﹤0.01% |
22,366
-7,512
| -25% | -$320K |
|
727
Exelixis
EXEL
$14B
| $903K | ﹤0.01% |
49,619
-6,440
| -11% | -$150K |
|
|
CCMP
728
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $894K | ﹤0.01% |
5,936
-150
| -2% | -$24.8K |
|
729
Leslie's
LESL
$10.8M
| $893K | ﹤0.01% |
+1,624
| New | +$891K |
|
730
MACOM Technology Solutions
MTSI
$20.1B
| $892K | ﹤0.01% |
+13,928
| New | +$808K |
|
|
DISH
731
DELISTED
DISH Network Corp.
DISH
| $890K | ﹤0.01% |
21,295
| – | – |
|
732
Installed Building Products
IBP
$6.16B
| $889K | ﹤0.01% |
7,266
+1,015
| +16% | +$124K |
|
733
Repligen
RGEN
$7.39B
| $871K | ﹤0.01% |
4,369
-65
| -1% | -$12.6K |
|
734
Invesco S&P 500 Low Volatility ETF
SPLV
$7.21B
| $859K | ﹤0.01% |
14,104
-1,660
| -11% | -$101K |
|
735
CONMED
CNMD
$1.31B
| $854K | ﹤0.01% |
6,216
-2,222
| -26% | -$304K |
|
|
MPT
736
Medical Properties Trust
MPT
$2.86B
| $854K | ﹤0.01% |
42,556
-1,184
| -3% | -$25.3K |
|
737
BJs Wholesale Club
BJ
$12.1B
| $841K | ﹤0.01% |
17,676
-30,089
| -63% | -$1.38M |
|
738
Lincoln National
LNC
$7.88B
| $841K | ﹤0.01% |
13,395
-435
| -3% | -$28.7K |
|
739
Franklin Electric
FELE
$4.66B
| $838K | ﹤0.01% |
+10,397
| New | +$852K |
|
|
AXON
740
Axon Enterprise
AXON
$42.4B
| $835K | ﹤0.01% |
4,732
+137
| +3% | +$20.2K |
|
741
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.77B
| $835K | ﹤0.01% |
22,360
| – | – |
|
742
JB Hunt Transport Services
JBHT
$26.4B
| $833K | ﹤0.01% |
5,120
-13
| -0.3% | -$2.19K |
|
743
Arrowhead Research
ARWR
$12B
| $831K | ﹤0.01% |
10,038
+31
| +0.3% | +$2.31K |
|
744
Clearway Energy Class C
CWEN
$5B
| $830K | ﹤0.01% |
31,350
+6,025
| +24% | +$165K |
|
|
BRKL
745
DELISTED
Brookline Bancorp
BRKL
| $829K | ﹤0.01% |
55,489
-2,677
| -5% | -$42.8K |
|
746
Omnicell
OMCL
$1.89B
| $828K | ﹤0.01% |
5,472
-258
| -5% | -$35.9K |
|
747
Macerich
MAC
$7.41B
| $827K | ﹤0.01% |
+45,360
| New | +$680K |
|
748
Toro Company
TTC
$9.01B
| $826K | ﹤0.01% |
+7,522
| New | +$827K |
|
|
CDK
749
DELISTED
CDK Global, Inc.
CDK
| $820K | ﹤0.01% |
16,521
-459
| -3% | -$24.3K |
|
750
Sanofi
SNY
$105B
| $819K | ﹤0.01% |
15,590
-6,108
| -28% | -$319K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2021 Portfolio in Review
As of Q2 2021, Glenmede Trust held 1,342 positions worth $19.3B, up 4.2% from $18.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Glenmede Trust's Q2 2021 filing shows 146 new, 332 increased, 638 reduced and 75 closed positions. Its largest new stake was Virtu Financial: 627,026 shares worth $17.3M. The largest sale was McKesson, an estimated $82.9M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Glenmede Trust's largest Q2 2021 buy was Virtu Financial: 627,026 shares worth $17.3M.
- Glenmede Trust added most to TJX Companies in Q2 2021, an estimated $37.2M increase.
- Glenmede Trust's biggest Q2 2021 reduction was McKesson, cutting an estimated $82.9M.
- Glenmede Trust fully exited Western Alliance Bancorporation in Q2 2021, selling an estimated $19.5M.
- Glenmede Trust's ten largest holdings make up 20% of its $19.3B portfolio in Q2 2021.
- Glenmede Trust opened 146 new positions and closed 75 in Q2 2021.
- Glenmede Trust's portfolio value rose 4.2% quarter-over-quarter to $19.3B.
Based on Glenmede Trust's 13F filing for Q2 2021, filed 16 Aug 2021.